Isis Pharmaceuticals, Inc. · Carlsbad, CA United States (NASDAQ: ISIS)
| 1896 Rutherford Rd. | Phone: 760-931-9200 |
| Carlsbad, CA | Fax: 760-603-2700 |
| 92008 | |
| United States | 
Map This Company |
Isis Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Electromedical Apparatus Mfg, Pharmaceutical Preparation MfgCompany Description
Isis Pharmaceuticals is trying to make sense out of antisense. The biotechnology company is developing drugs based on its antisense technology, in which drugs attach themselves to strands of RNA in order to prevent them from producing disease-causing proteins; the hoped-for end result is a therapy that fights disease without harming healthy cells. Isis Pharmaceuticals' strategy is to discover more potential drug compounds that it can develop on its own and then license them off to larger drug firms, thus producing a potential stream of revenue (in the form of milestone payments and royalties) for itself. Its lead candidate is the cholesterol-lowering drug mipomersen, which Isis has licensed to
Isis Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ISIS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 270 |
Executives
39 executives listed for Isis Pharmaceuticals, Inc.'s Carlsbad, CA location.
| Chairman, President, and CEO | Stanley Crooke | |
|---|---|---|
| COO, CFO, Secretary, and Director | B. Lynne Parshall | |
| VP and Chief Medical Officer | Walter Singleton |